Placental pathology: its impact on explaining prenatal and perinatal death by Stallmach, Thomas & Hebisch, Gundula
Virchows Arch (2004) 445:9–16
DOI 10.1007/s00428-004-1032-2
R EV I EW ART I C L E
Thomas Stallmach · Gundula Hebisch
Placental pathology: its impact on explaining prenatal
and perinatal death
Received: 27 November 2003 / Accepted: 15 April 2004 / Published online: 11 May 2004
 Springer-Verlag 2004
Abstract This review considers six main situations in
which pathologists are expected to report and interpret
placental messages for obstetricians, neonatologists and,
indirectly, parents: (1) abortion is the body’s corrective
response to the embryonic defect suggested by malformed
chorionic villi; (2) infection causing chorionic villous
inflammation is specific and haematogenous; pathogen
identification is mandatory, in contrast to chorioamnion-
itis caused by increased local immunosuppression al-
lowing indiscriminate bacterial entry; (3) prematurity and
(4) intrauterine growth restriction are often associated
with pregnancy-specific disease (pre-eclampsia) or pre-
existing maternal conditions (systemic lupus); parental
studies may improve outcome in subsequent pregnancies;
(5) intrauterine death near term is often due to placental
dysmaturity featuring a severely reduced number of
syncytiocapillary membranes; it accounts for the death in
utero of 3 in 1000 pregnancies; detection helps to mini-
mise recurrence in subsequent pregnancies; (6) twins are
best confirmed as monozygous by the absence of chori-
onic tissue in the dividing membranes; most monochori-
onic twins have vascular connections whose detailed
analysis is requested only if there are inter-twin differ-
ences in growth and colour. From a formal point of view,
many more bits of pathology than discussed in this review
can be found in placentas and, with the advances in ul-
trasonography, might even be seen prior to birth. The
extent of such a disturbance might ultimately affect fetal
growth, which is amenable to prenatal detection offering
the chances for an appropriate management. In contrast,
dysmaturity is a great challenge as no predictive tests are
as yet available.
Keywords Placenta · Pathology · Abortion · Infection ·
Intrauterine growth restriction
Introduction
Examination of the placenta by the pathologist is
mandatory in cases of abortion, fetal malformation, in-
fection, growth restriction, pre-eclampsia, late intrauter-
ine death, intra-partum hypoxia (documented deteriora-
tion of the cardiotocogram or low pH immediately post-
partum) and complicated twin pregnancy (feto-fetal
transfusion syndrome, differences in body weight, zy-
gosity). The pathologist needs a written request from the
clinician, with information to include (at a minimum) the
week of gestation, fetal weight, maternal health during
pregnancy and the indications for referral (ideally in the
form of the questions that the clinician would like to have
answered).
Abortion (miscarriage)
Some 50% of all conceptions are thought to end in early
abortion, many unnoticed. Timing life from the sperm’s
entry into the egg, John Opitz [17] said: “Most men die
before birth, not after birth”. Human reproductive failure
is characterised less by resorption (as in mice) than by the
expulsion of the products of conception. For the pathol-
ogist who receives the decidua with a line of demarcation
and placenta, the single most important question is: are
the chorionic villi normal? If ‘No’, it can be assumed that
abortion has corrected an earlier mistake.
Chromosomal analysis of early and very early abortion
tissue reveals a high proportion of pathological karyo-
types [4, 12, 26], including tetraploidy, triploidy and tri-
somy of all chromosomes (with the sole exception to date
of trisomy 1). Via an unknown mechanism, the maternal
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organism detects and aborts these chromosomal patholo-
gies. Although such karyotypes are compatible with
limited trophoblastic and chorionic development, the ar-
chitecture of the resulting chorionic villi, stratification of
trophoblast layers, vascularisation and stromal density are
abnormal (Fig. 1). Generally speaking, abnormal chori-
onic villi are mostly due to an abnormal karyotype, i.e. a
genetic abnormality that—with very rare exceptions—is
sporadic. Prolongation of such a pregnancy is neither
desirable nor feasible. Precise characterisation of the
chromosomal abnormality, e.g. trisomy of which chro-
mosome, requires living cells for fibroblast culture and
karyotype analysis. Alternatively, formalin-fixed, paraf-
fin-embedded material can be subjected to comparative
genomic hybridisation to detect the surplus DNA derived
from the extra chromosome [5, 7] (Fig. 1d). Both methods
are laborious and expensive, and the information retrieved
is not required by the individual patient. If the parents
wish for another child, there is no clearly defined need for
a period of contraception.
If the chorionic villi are normal, on the other hand, this
is bad news for the mother, since the assumption must be
that she has aborted a potentially normal child. The rea-
sons are not usually evident from the histology. Recur-
rence can be common. Many clinicians consider further
exploration or a period of contraception helpful [25].
Recurrent abortion is defined by three consecutive early
abortions of identical type, ideally with the chorionic villi
showing the same disturbed architecture. Only then is
parental karyotype analysis indicated. It occasionally de-
tects a balanced chromosomal abnormality in one parent
as the repeated cause of imbalance in the conceptus [1].
Infection
Irrespective of the cause of pregnancy failure, abortion
material reveals inflammation as part of the desquamation
process of devitalised tissues. In contrast, inflammation
Fig. 1 Early chorionic villus morphology and karyotype. A Normal
chorionic villi show uniform branching architecture, trophoblast
layering and stromal density. Polar proliferations of cytotrophoblast
(arrow) are normal in early pregnancy. Haematoxylin and eosin
(H&E), 80. B Malformed villi are often large with irregular
contours and syncytiotrophoblast piling (arrow). H&E, 80. C The
great diversity of abortifacient abnormal karyotypes is reflected in a
variety of patterns of chorionic villus malformation. In this exam-
ple, the dominant feature is stromal heterogeneity. H&E, 80.
D Ideogram of comparative genomic hybridisation analysis of
DNA from a paraffin block with malformed chorionic villi (probe).
The extracted DNA has a female karyotype and is hybridised on a
normal male metaphase preparation: the Y chromosome is red
because no corresponding DNA is present in the probe DNA
(green). The X chromosome is green because of a surplus of X-
derived DNA in the probe (ratio 2:1). Both chromosomes 13 are
bright yellow compared with all other chromosomes because of a
surplus of chromosome 13-derived probe DNA (ratio 3:2). The
technology establishes the karyotype in different areas of the pla-
centa with different morphology in cases of suspected mosaicism,
but is not recommended for routine use. (Source: Scharpf P, doc-
toral thesis, Zurich 2002)
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due to infection becomes more prevalent from 16 weeks
of pregnancy onwards.
There are two main scenarios. The first is that of so-
called ascending amniotic infection [19], which is re-
cognised by neutrophilic infiltrates in the membranes,
chorionic plate and umbilical cord. At autopsy, the fe-
tus—even when submitted without the placenta—readily
reveals the diagnosis by increased hepatic granulopoiesis,
ingested and aspirated granulocytes and the formation of
bronchus-associated lymphatic tissue in the lungs (Fig. 2).
The most sensitive finding is the presence of segmented
neutrophilic (maternal) granulocytes within the fetal al-
veoli. However, care should be taken to discriminate
apoptotic fetal cells from the alveolar lining. Furthermore,
granulocyte aspiration and ingestion can be completely
missing following oligohydramnios (preceding premature
rupture of the membranes). Increased granulopoiesis
within the fetal liver sinusoids, i.e. more than 15 granu-
lopoietic cells per high power field (excluding the portal
tract, where brisk granulopoiesis is physiological) visu-
alised with a chloracetate esterase stain, is, thus, a more
reliable indicator [22]. The formation of bronchus-asso-
ciated lymphatic tissue can be most striking, however, and
is seen in fetuses exposed to chorioamnionitis for several
days [9]. Organism culture and special stains are not re-
quired. However, if the cord shows macroscopic yellow
spots or histological evidence of superficial necrotising
inflammation, there is a high suspicion of fungal infec-
tion, and periodic acid-Schiff staining for Candida is in-
dicated.
The alternative scenario is haematogenous infection of
the fetus, indicated by inflammation within the chorionic
villi. In bacterial infections, granulocytes predominate
while lympho-plasmocytic infiltration usually signifies
cytomegalovirus (CMV) infection in developed countries.
Whereas most viral infections can only access the fetus
after primary infection of the mother during pregnancy
[parvovirus infection, varicella (chickenpox), rubella
(German measles) and toxoplasmosis], reactivation of
latent maternal CMV infection can severely damage the
fetus.
Haematogenous infection of the fetus is a mandatory
indication for pathogen identification [3, 15]. It is the
example par excellence of infectious disease. Chorioam-
nionitis, however, is not, since its most likely primary
cause is an imbalance between fetal trophoblast invasion
and maternal adaptation. Presumably, this results in a
surplus of local immunosuppression and facilitates the
ascension of bacteria from the vagina. Infection, then, can
be caused by any of the bacteria present in the urogenital
and intestinal tract, obviating in general the need to
identify them as “pathogens”.
Prematurity
Very immature newborns (24–28 weeks of gestation) are
often the product of medical intervention designed to
rescue either the fetus from adverse in utero conditions or
the mother from the consequences of pre-eclampsia.
Pregnancy is usually terminated by caesarean section
timed by risk-factor assessment following the induction of
fetal lung maturation using cortisone given to the mother.
Placentas should be sent for examination to document
the antenatal diagnosis. Amniotic infection (see above), at
some stage, induces labour, which cannot be stopped.
Maternal inflammatory parameters (fever, C-reactive
protein) and contraction intensity often correlate quite
well with the intensity of placental inflammation, pro-
vided that at least two strips of extraplacental membranes,
two to three segments of umbilical cord and three blocks
from the placenta are examined [14, 29].
In contrast, pre-eclampsia does not induce uterine
contractions. Termination is usually indicated on maternal
Fig. 2 Fetal lung with amniotic infection syndrome (chorioamni-
onitis). A Segmented maternal granulocytes aspirated into the al-
veoli from amniotic fluid. This should not be diagnosed as ‘pneu-
monia’. The absence of aspirated granulocytes in otherwise un-
equivocal chorioamnionitis indicates oligohydramnios. Chloroac-
etate esterase stain, 250. B Longstanding chorioamnionitis pro-
duces bronchus-associated lymphatic tissue. Lymphocytes labelled
with CD45 antibody, 400
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grounds (oedema, proteinuria, hypertension and coagu-
lation abnormalities). Pre-eclamptic placentas are usually
below the fifth percentile for weight and size and display
circulatory abnormalities in the intervillous space (in-
farcts of different age and size, thromboses). Very char-
acteristic findings are seen in the underlying decidua,
which is often inadequately represented in the usual pla-
cental blocks. When more of the basal plate tissue is re-
tained, or the tissue submitted derives from curettage of
the placental bed, a lack of trophoblast invasion can be
seen [23]. Sometimes this goes along with a relative in-
crease of multinucleated trophoblast cells clustered, albeit
at some distance, around spiral arteries. These arteries
themselves are narrow and show acute atherosis (Fig. 3).
Similar placental findings can be present in mothers after
organ (mostly kidney) transplantation and mothers with
underlying autoimmune disease (lupus erythematosus).
Pre-eclampsia seems to be an aetiologically hetero-
geneous disorder. Late onset disease, greater than
34 weeks [30], usually does not restrict fetal growth [18],
and, in most cases, the characteristic findings within and
around spiral arteries are missing. There may be signs of
intervillous circulatory disturbance; however, this in-
creases anyway, to some extent, towards term. Mean-
ingful research in this field has to take into account that
clinical pre-eclampsia comprises at least two different
conditions.
Intrauterine growth restriction
Serial fetal ultrasonography can now detect deviations
from a growth curve that is initially unremarkable. Al-
though this usually indicates a placental problem, there
are multiple conditions that can restrict fetal growth
(Table 1). The fetal growth curve evidences placental
malfunction in the nutritional supply line and—as in
children and adults—some time is required before death
ensues. Given proper monitoring, fetal starvation is usu-
ally only fatal if it starts very early in pregnancy, when
the risks of extreme prematurity put severe restrictions on
caesarean section. The placenta of a growth-restricted
child is almost always small (below the fifth percentile).
However, if small size is the only placental abnormality,
the term “placental insufficiency” is inappropriate, as the
placenta will be small like any other fetal organ if the
child is small for a non-placental reason. Thus, any ge-
netic condition (e.g. uniparental disomy) or toxin (e.g.
heavy smoking) that restricts fetal growth will also cause
a small placenta. To identify a small placenta as a primary
cause of fetal growth restriction, additional findings are
required, e.g. impaired maternal blood flow through the
intervillous space (infarcts) or impaired fetal blood flow
through the cord and allantoic vessels or chorionic villi
(fetal thrombotic vasculopathy) [13, 20]. Rarely, the
combination of impaired maternal and fetal circulation
Fig. 3 Spiral artery pathology. A Acute atherosis is characterised
by greater arterial density and a narrower arterial lumen on cross-
section (compare the physiological transformation in D) and dis-
tinctive, strongly eosinophilic, hyaline replacement of the media.
Haematoxylin and eosin (H&E), 100. B In acute atherosis, the
vessel wall is devoid of trophoblast cells (compare with E).
Multinucleated trophoblast cells (none shown) may sometimes be
present at a distance from the pathological vessels. Pancytokeratin,
100. C High-power cross-sections in acute atherosis revealing
segments with intimal foam cells. H&E, 250. D Physiologically
transformed spiral arteries are less coiled (fewer aggregated cross-
sections); the muscle coat is replaced by (less eosinophilic) fi-
brinoid material (compare with acute atherosis in A). H&E, 100.
E Physiologically transformed spiral artery containing fetal tro-
phoblast cells labelled with pancytokeratin antibody, 100
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may reveal a combination of different—and perhaps as
yet unknown—thrombophilic traits inherited by the fetus
[6, 10, 28] (Fig. 4).
The functional reserve capacity of the placenta is
usually given as 30%. However, live-born severely
growth-restricted children are occasionally observed with
placentas containing barely 30% of functional tissue. This
makes it difficult to ascribe the in utero death of a
severely dystrophic fetus merely to loss of functional
placental tissue and starvation. The cause of death is ra-
ther a sudden additional pathology, e.g. focal abruptio
from the decidua. Hence, the need for meticulous in-
spection to identify and report abruptio, even if focal and
discrete.
Autopsy organ dimensions and weights in a small,
non-malformed fetus can reveal two patterns. If all mea-
sures are similarly small, the placenta is a most unlikely
cause. If the brain and feet are of normal size while the
heart and kidney are small, and organs such as liver,
spleen and thymus are very small, the asymmetry sug-
gests insufficiency of the placental supply line. The risk
of recurrence depends on the underlying condition caus-
ing the placental growth retardation and circulatory def-
icit. Even if unexplained, recurrence is readily detected by
monitoring fetal growth during the next pregnancy. Some
centres give prophylactic anticoagulation using heparin or
aspirin alone or in combination [2, 11].
Fig. 4 Impaired fetomaternal circulation in the placenta. A Fetal
thrombotic vasculopathy in a stem villus with two patterns: fresh
thrombosis (arrow) followed by obliterating intimal proliferation
(two arrows) and so-called haemorrhagic endovasculitis (arrow-
heads). B Obliteration of the maternal intervillous blood space by
fibrin. Intervillous granulocytes and monocytes accompany the
florid thrombotic process (haematogenous infection may show the
same infiltrate but within the chorionic villi). C Genetic analysis of
the female fetus fed by the above placenta and of the parents. Semi-
shaded symbols denote two fetuses affected by a severely impaired
placental circulation. No genetic analysis was performed of the first
Table 1 Possible causes of intrauterine growth restriction
(A) Physical environment, mind, drugs
Poor maternal nutritional status (low pre-pregnancy weight,
vegetarians)
Residence at high altitude (>5000 m above sea level)
Stress factors (mental, physical, emotional)
Drugs (nicotine, alcohol, medical and illegal drugs)
(B) Pre-existing disease
Cardiovascular (heart defects, heart insufficiency)
Respiratory diseases (asthma)
Haematological diseases (chronic anaemia,
haemoglobinopathies)
Gastrointestinal disorders (M. Crohn, ulcerative colitis)
Renal transplantation, haemodialysis
Chronic infections
Immunological disorders (systemic lupus erythematodes,
anti-phospholipid-antibody syndrome)
(C) Pregnancy-specific disorders
Hypertensive disorders of pregnancy (pre-eclampsia,
HELLP syndrome)
Chronic vaginal haemorrhage, retroplacental haematoma
Multiple pregnancy
(D) Fetal cause
Fetal malformation (aneuploidy, single gene disorders,
sporadic)
Fetal infections (toxoplasmosis, CMV, others)
Placental mosaicism and uniparental disomy
death at 23 weeks in 1981. Small symbols denote the genes anal-
ysed. The 19-week fetus is the double heterozygote infant of a
family segregating a prothrombin gene mutation, factor V (Leiden)
and protein S deficiency
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Intrauterine death near term
Of 1000 pregnancies that have progressed uneventfully to
fetal viability, 3–4 will result in the catastrophe of sudden
and silent in utero death. This represents one-half of
perinatal mortality in highly developed countries. “Sud-
den” means the absence of warning, even in retrospect,
from either maternal symptoms or fetal measurements.
Given these circumstances, it is conceivable that the fetus
has died from hypoxia, as either a single or repeated
event. This makes it clear that the placental delivery of
oxygen is not coupled to that of nutrients. A well-ac-
cepted cause is sudden premature abruptio; however, this
produces symptoms in the mother and is, thus, not silent.
In most other cases, mothers only present days after the
child has died in utero because they have noticed the lack
of fetal movements. Labour has to be induced to deliver
the macerated child. At autopsy, so-called hypoxic
haemorrhages are seen in the pleura, pericardium and
meninges, and the approximate interval between death in
utero and delivery can be estimated from the histology of
the heart and lung [8].
The most common cause is placental dysmaturity or
placental maturation defect [24]. Such placentas are of
normal size or even large, but with a pale cut surface. In
some cases of dysmaturity, the indication for examination
by the pathologist is the midwife’s observation that the
placenta is pale. The pallor is due to defective formation
of both the sinusoidal vessels in the terminal villi and the
syncytiocapillary membranes. Sinusoidal vessels with
broad contact and a short diffusion distance to maternal
blood have been equated with impaired placental respi-
ratory function and, thus, the risk of asphyxia. In its
smallest and most mature terminal villi, a normal late
pregnancy placenta (35 weeks) has an average of three
sinusoidal contacts with the surrounding maternal blood
(Fig. 5). A dysmature placenta has an average of one such
structure per terminal villus. About 5% of unselected
placentas examined without indication reveal this pattern,
and, up to now, there is no clue as to its cause. Although
only 2% of fetuses with a dysmature placenta will actu-
ally die, this risk is 70-fold that of a fetus with a normal
placenta [24]. A mother who has lost a child due to pla-
cental dysmaturity has a tenfold higher risk of recurrence
compared with baseline. No predictive markers are
presently available: placental dysfunction is manifested
only as a terminal acute event. To minimise recurrence in
a subsequent pregnancy, one option is to induce labour at
completed 37 weeks, although this must be balanced
against the risks of premature birth.
The concept of dysmaturity as a cause of fetal death is
not yet widely accepted. A counter-argument is that fe-
tuses dying from this supposed hypoxia are a minority.
The answer is very simple: most fetuses are rescued by
birth, as their placenta is required to function for only a
few weeks more. Pathologists know how difficult it is to
predict final decompensation in a diseased organ. For
example, severely glomerulonephritic kidneys can force
haemodialysis within a few weeks, but they can also stay
functional for another couple of years.
Twin pregnancy
With very rare exceptions [21], a monochorionic twin
pregnancy identifies the newborns as “identical” (mono-
zygous). Thus, the fusion of placental tissues is consid-
ered an indication for histological examination of the
dividing membrane. If the membrane contains chorionic
tissue, it means that the twins lived in separate chorionic
cavities. They still might be “identical”. However, the rate
of complications is low. In contrast, lack of chorionic
tissue in the dividing membrane signifies a monochori-
onic cavity, which in most cases goes along with feto-
Fig. 5 Chorionic villus maturation in late pregnancy. A Normal
maturation leads to a dominance of terminal villi with several
syncytiocapillary membranes (arrowheads) per cross-section from
36 weeks onwards. Haematoxylin and eosin (H&E), 250. B A
dysmature term placenta has many fewer syncytiocapillary mem-
branes (arrowheads); chorionic villi may be plumper. H&E, 250
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fetal vascular connections. If both twins are alive and
similar in weight and colour (haemoglobin, haematocrit),
there is no need for elaborate study of vessel connections.
Intrauterine death and discrepancies of weight and colour,
on the other hand, indicate the need to examine the
chorionic plate for large connections. This can usually be
performed within a few minutes by insufflation of the
artery and vein of either umbilical cord using an air-filled
syringe. Arteriovenous fistulas in the depths of the coty-
ledons are betrayed by small branches of arteries or veins
coming from disparate sides and leading into the same
area of the chorionic plate. These fistulas are usually
multiple, although unbalanced in net blood flow [16, 27].
The imbalance is rescued by large connections, mostly
arterio-arterial anastomoses, within the chorionic plate.
However, these have their own intrinsic risk. If due to
other causes, the condition of one twin deteriorates
(eventually going along with a drop in its blood pressure),
its circulation is overtransfused by the stronger pumping
action (effecting a higher blood pressure) of the co-twin’s
heart.
Feto-fetal vascular connections are sometimes de-
stroyed by laser coagulation. If this therapy is incomplete,
it risks destabilising a previously labile balance in recip-
rocal transfusion. Some clinicians are, therefore, con-
cerned to confirm successful coagulation of all connecting
vessels after birth by examination of the placenta.
Conclusion
Examination of a placenta is clearly indicated in every
pregnancy failure, as it can reveal underlying systemic
causes and/or the risk of recurrence. Placentas should also
be examined from children who survive birth but have an
unexplained low Apgar score, infection or growth retar-
dation. The routine storage of all placentas for at least
3 days is recommended, should the need for examination
be dictated by subsequent deterioration in the newborn.
From a formal point of view, many more bits of pathology
than discussed in this review can be found in placentas
and, with the advances in ultrasonography, might even be
seen prior to birth, e.g. a “cyst” representing a subchorial
haematoma. The extent of such a disturbance might ul-
timately affect fetal growth, which is amenable to prenatal
detection offering the chances for an appropriate man-
agement. More to be feared is sudden deterioration,
mostly by abruptio of the placenta. Dysmaturity causing
sudden death due to hypoxia is the greatest challenge, as
there are no premonitory signs and no predictive tests as
yet available.
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